Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Protego Announces FDA IND Clearance for Phase 2/3 Study of PROT-001 in AL Amyloidosis
-
Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
-
Complete Comfort Heating, Air and Plumbing provides steps to prepare for winter
-
Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
-
NRG Energy, Inc. Announces Quarterly Dividend
-
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
-
Copper Road Announces Management Changes
-
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
-
Erdene Provides Q3 2026 Update and Notice of Conference Call and Webcast
-
Major Drilling Announces Renewal of Normal Course Issuer Bid
-
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
-
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
-
Customers Can Now Purchase the 2027 Toyota Corolla Hatchback in Vacaville, California
-
Second Porphyry Discovery Confirmed at La Verde
-
Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap
-
Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call
-
EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD
-
Max Stock to hold November 22 EGM on reappointment of external directors
-
Bucked Up®, the #1 Pre-Workout in the U.S., Launches at Target Nationwide
-
Julia Gillard joins Hakluyt's International Advisory Board
-
Hornbeck Offshore Announces Third Quarter 2026 Earnings Release and Conference Call Schedule
-
Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan
-
CME Group Expands Dairy Business with New European Futures and Options
-
Graphite One Highlights Strategic Importance of Alaska's Graphite Creek Project
-
Summit Therapeutics Announces Opening of Global Phase II Study of Ivonescimab-Based Regimens in Advanced Clear Cell Renal Cell Carcinoma
-
Berkshire Hathaway Specialty Insurance Announces Entry Into Poland and Carsten Keune as Country Manager
-
PTC to Announce Fourth Fiscal Quarter and Full Year 2026 Results on Wednesday, November 4, 2026
-
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
-
TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine
-
InstaMall Launches Same-Day Fashion Delivery Experience, Bringing 80+ Brands to Shoppers' Doors in Miami
-
AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® (durvalumab), TAGRISSO® (osimertinib) and savolitini
-
Simply Healthcare and Preeclampsia Foundation Partner to Address Critical Maternal Health Risks in Florida
-
2026 Canton Fair Design Award Winners Showcase China's Innovation Strength
-
Silgan Announces Strategic Portfolio Acceleration; Establishes Partnership to Acquire Trivium
-
Discoveries Today Examines How Innovation Is Expanding Access, Strengthening Security, and Transforming Business Operations.
-
Frontier Medicines to Present First Clinical Data for FMC-376, an Equipotent KRAS G12C ON+OFF Inhibitor, at ESMO Congress 2026
-
United Therapeutics Announces FDA Clearance to Proceed with SUMMIT Clinical Trial for Treprostinil SMI in PH-COPD
-
Sylogist Announces CFO Transition, Appoints David Miller as Chief Operating Officer
-
Zipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS Metastases
-
SES AI Completes Ramp of Korea Drone Battery Plant to One Million NDAA-Compliant Cells Per Year, and Plans to Further Expand to Three Million NDAA-Compliant Cells Per Year by Second Quarter 2027
-
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Loss
-
monday.com to Announce Third Quarter 2026 Financial Results on Monday, November 9, 2026
-
BlackSky to Host Third Quarter 2026 Results Conference Call
-
HNTB-designed O'Hare South Conveyance Storm Sewer Project earns Outstanding Civil Engineering Achievement Award
-
Origin Agritech Announces Strategic Provincial Distribution Agreement for Corn Seeds in Shandong Province and Receives RMB 2.9 Million in Initial Payments
-
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NA
-
EquipmentShare Raises 2026 Financial Outlook on Strong Performance and Customer Demand
-
Teamshares Retires Legacy Credit Facility with Term Loan Maturing 4Q 2030
-
Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar
-
Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap
